2,5-Bis-O-[4-[[4-[[[4-(acryloyloxy)butoxy]carbonyl]oxy]benzoyl]oxy]benzoyl]-1,4:3,6-dianhydro-D-glucitol>85.0%(HPLC)1g

beta-Methylstyrene (cis- and trans- mixture) (stabilized with TBC)>95.0%(GC)25mL

(3R,4S)-4-(3-Chlorophenyl)pyrrolidine-3-carboxylic acid, 95.0%, 100mg

1-Bromo-3-(ethylsulfonyl)benzene, 95.0%, 250mg

4-Chloro-2-methylthieno[2,3-d]pyrimidine, 97.0%, 25g

4-(4-Amino-1-butyl)-morpholine, 98.0%, 1g

Benzo[d]thiazole-5-carbaldehyde, 95.0%, 5g

2-Ethoxythiazole, 98.0%, 10g

2-Amino-1-piperidin-1-yl-ethanone hydrochloride, 98.0%, 500mg

2-hydrazinyl-4-(1H-pyrazol-1-yl)pyrimidine, 95.0%, 250mg

4-Amino-1-((2R,3R,4R,5R)-4-hydroxy-5-(hydroxymethyl)-3-(2-methoxyethoxy)tetrahydrofuran-2-yl)-5-methylpyrimidin-2(1H)-one, 95+%, 100mg

Ethyl 6-chloro-3,4-dihydro-2H-benzo[b][1,4]oxazine-2-carboxylate hydrochloride, 98%, 250mg

N-(5-Bromothiazol-2-yl) acetamide hydrobromide, 95.0%, 25g